Correlation Between BriaCell Therapeutics and Valneva SE

Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BriaCell Therapeutics Corp and Valneva SE ADR, you can compare the effects of market volatilities on BriaCell Therapeutics and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and Valneva SE.

Diversification Opportunities for BriaCell Therapeutics and Valneva SE

-0.82

Correlation Coefficient

BriaCell Therapeutics  Valneva SE

Pay attention - limited upside

The 3 months correlation between BriaCell and Valneva is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and Valneva SE go up and down completely randomly.

Pair Corralation between BriaCell Therapeutics and Valneva SE

Assuming the 90 days horizon BriaCell Therapeutics Corp is expected to under-perform the Valneva SE. In addition to that, BriaCell Therapeutics is 1.88 times more volatile than Valneva SE ADR. It trades about -0.15 of its total potential returns per unit of risk. Valneva SE ADR is currently generating about 0.19 per unit of volatility. If you would invest  432.00  in Valneva SE ADR on December 30, 2024 and sell it today you would earn a total of  294.00  from holding Valneva SE ADR or generate 68.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	83.87%
Values	Daily Returns

BriaCell Therapeutics Corp  vs.  Valneva SE ADR

BriaCell Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days BriaCell Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Valneva SE ADR

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Valneva SE ADR are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Valneva SE displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BriaCell Therapeutics and Valneva SE

The main advantage of trading using opposite BriaCell Therapeutics and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.

The idea behind BriaCell Therapeutics Corp and Valneva SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.